Amphastar Pharmaceuticals Price to Book Ratio 2012-2024 | AMPH

Historical price to book ratio values for Amphastar Pharmaceuticals (AMPH) over the last 10 years. The current price to book ratio for Amphastar Pharmaceuticals as of November 20, 2024 is 2.92.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Amphastar Pharmaceuticals Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-11-19 43.62 2.90
2024-09-30 48.53 $15.04 3.23
2024-06-30 40.00 $14.57 2.75
2024-03-31 43.91 $13.77 3.19
2023-12-31 61.85 $13.30 4.65
2023-09-30 45.99 $12.43 3.70
2023-06-30 57.47 $12.07 4.76
2023-03-31 37.50 $11.39 3.29
2022-12-31 28.02 $10.99 2.55
2022-09-30 28.10 $10.39 2.70
2022-06-30 34.79 $10.19 3.41
2022-03-31 35.90 $9.84 3.65
2021-12-31 23.29 $9.34 2.49
2021-09-30 19.01 $8.97 2.12
2021-06-30 20.16 $9.74 2.07
2021-03-31 18.32 $9.45 1.94
2020-12-31 20.11 $9.45 2.13
2020-09-30 18.75 $9.49 1.98
2020-06-30 22.46 $9.32 2.41
2020-03-31 14.84 $9.14 1.62
2019-12-31 19.29 $9.18 2.10
2019-09-30 19.83 $9.19 2.16
2019-06-30 21.11 $9.16 2.31
2019-03-31 20.43 $8.07 2.53
2018-12-31 19.90 $7.81 2.55
2018-09-30 19.24 $7.39 2.60
2018-06-30 15.26 $6.91 2.21
2018-03-31 18.75 $7.01 2.67
2017-12-31 19.24 $7.16 2.69
2017-09-30 17.87 $7.20 2.48
2017-06-30 17.86 $7.21 2.48
2017-03-31 14.50 $7.08 2.05
2016-12-31 18.42 $7.12 2.59
2016-09-30 18.97 $7.13 2.66
2016-06-30 16.12 $6.82 2.36
2016-03-31 12.00 $6.60 1.82
2015-12-31 14.23 $6.54 2.18
2015-09-30 11.69 $6.28 1.86
2015-06-30 17.58 $6.29 2.79
2015-03-31 14.96 $6.25 2.39
2014-12-31 11.61 $6.31 1.84
2014-09-30 11.65 $6.34 1.84
2014-06-30 10.01 $6.45 1.55
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $2.097B $0.644B
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00
Teligent (TLGT) United States $0.000B 0.00